GCI buys biotech specialist shop

SAN FRANCISCO: Seeking to bolster its 10-month-old health technology practice, GCI Group has acquired Russell-Welsh, a small Silicon Valley biotech specialist.

SAN FRANCISCO: Seeking to bolster its 10-month-old health technology practice, GCI Group has acquired Russell-Welsh, a small Silicon Valley biotech specialist.

SAN FRANCISCO: Seeking to bolster its 10-month-old health

technology practice, GCI Group has acquired Russell-Welsh, a small

Silicon Valley biotech specialist.



Founded in 1991 by former Cetus exec Katharine Russell, Russell-Welsh

specializes in IR and PR for start-up life sciences companies.



’We’re building a practice that serves the needs of young companies,

whose main concern is pre-IPO IR, and mature companies, where PR and IR

are more overlapping,’ said GCI health tech director and SVP Paul

Laland, who established the practice group when he arrived from

Genentech last summer.



GCI healthcare EVP and MD Bob Pearson hinted at further acquisitions in

the healthcare space: ’Let’s just say we are very committed to growth in

the healthcare arena, especially internationally.’



The deal is further evidence that the hot biotech sector has grabbed the

attention of multinational firms. Ogilvy took its dip into the biotech

pool last November when it purchased Feinstein Kean Partners, a dollars

9.1 million Cambridge, MA-based biotech specialist, for a rumored

dollars 12-15 million in cash and/or WPP stock.



Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.